Glenmark Pharmaceuticals Ltd - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Pursuant to the Regulation 30 and 46 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we hereby confirm that we have uploaded audio recording of Q2 FY 2025-26 Earnings Call held on 17th November, 2025 on the website of the Company